Addressing the tax regime in the Pharmaceutical Industry
The Kenya Kwanza government promised to work with the pharmaceutical industry to address the tax regime and cost of doing business.
While there was a proposal to move raw materials for the production of pharmaceutical products from Zero-rated to Tax-Exempt in the 2025 Finance Bill, the proposal was not carried forward to the Finance Act.
